Avestar Capital LLC Buys Shares of 10,800 Healthpeak Properties, Inc. (NYSE:DOC)

Avestar Capital LLC bought a new stake in Healthpeak Properties, Inc. (NYSE:DOC) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 10,800 shares of the real estate investment trust’s stock, valued at approximately $247,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in DOC. Charles Schwab Investment Management Inc. purchased a new stake in Healthpeak Properties in the third quarter valued at approximately $230,988,000. Sumitomo Mitsui Trust Group Inc. purchased a new stake in shares of Healthpeak Properties during the third quarter worth $102,615,000. FMR LLC purchased a new stake in shares of Healthpeak Properties during the third quarter worth $67,058,000. abrdn plc purchased a new stake in shares of Healthpeak Properties during the third quarter worth $62,670,000. Finally, Swiss National Bank purchased a new stake in shares of Healthpeak Properties during the third quarter worth $47,774,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Trading Down 0.4 %

NYSE DOC opened at $22.23 on Thursday. The stock has a market capitalization of $15.55 billion, a P/E ratio of 47.30, a P/E/G ratio of 2.45 and a beta of 1.13. Healthpeak Properties, Inc. has a 52-week low of $16.01 and a 52-week high of $23.26. The firm has a 50-day moving average price of $22.18 and a 200 day moving average price of $21.20. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.44 by ($0.32). The firm had revenue of $700.40 million for the quarter, compared to analysts’ expectations of $682.51 million. Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The company’s revenue for the quarter was up 25.9% on a year-over-year basis. During the same period in the prior year, the company earned $0.45 earnings per share. Equities research analysts expect that Healthpeak Properties, Inc. will post 1.8 EPS for the current year.

Healthpeak Properties Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were issued a $0.30 dividend. The ex-dividend date was Monday, November 4th. This represents a $1.20 dividend on an annualized basis and a yield of 5.40%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 255.32%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on DOC shares. Robert W. Baird upped their price objective on Healthpeak Properties from $24.00 to $25.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Wells Fargo & Company reaffirmed an “equal weight” rating and set a $23.00 price objective (up previously from $22.00) on shares of Healthpeak Properties in a research report on Tuesday, October 1st. Scotiabank upped their price objective on Healthpeak Properties from $23.00 to $24.00 and gave the stock a “sector outperform” rating in a research report on Monday, September 9th. Deutsche Bank Aktiengesellschaft raised Healthpeak Properties from a “hold” rating to a “buy” rating and upped their price objective for the stock from $20.00 to $28.00 in a research report on Monday, October 21st. Finally, Citigroup upped their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $22.86.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.